clinical trial · NCT06346600
A Long-term Follow-up Study to Evaluate SKG0106 in the Treatment of Patients With nAMD
Neovascular (Wet) Age-related Macular DegenerationSKG0106
brief summary
This is a Prospective, Non-interventional, Multicenter, Long-term Follow-up Study to Evaluate SKG0106 in the Treatment of Patients with Neovascular (Wet) Age-related Macular Degeneration (nAMD). All subject who completed the parent clinical study (NCT06213038 and NCT05986864) will undergo safety and efficacy assessments up to 5 years post study drug injection.
started
Apr 2, 2024
primary completion
Mar 1, 2031
completion
Mar 1, 2031
last updated
Apr 4, 2024
official title
A Prospective, Non-interventional, Multicenter, Long-term Follow-up Study to Evaluate SKG0106 in the Treatment of Patients With Neovascular (Wet) Age-related Macular Degeneration (nAMD)
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol